Effective November 28, 2023, Aeglea BioTherapeutics, Inc. will change its name to Spyre Therapeutics, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.29 USD | +6.19% | +14.75% | +82.57% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.57% | 1.58B | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.64% | 21.25B | |
-5.61% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Aeglea BioTherapeutics, Inc. will Change its Name to Spyre Therapeutics, Inc